Dermapharm Holding SE
XETRA:DMP

Watchlist Manager
Dermapharm Holding SE Logo
Dermapharm Holding SE
XETRA:DMP
Watchlist
Price: 34 EUR 8.63% Market Closed
Market Cap: 1.8B EUR
Have any thoughts about
Dermapharm Holding SE?
Write Note

Dermapharm Holding SE
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Dermapharm Holding SE
Long-Term Debt Peer Comparison

Comparables:
ATAI
BAYN
MRK
93M1
PSG

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Dermapharm Holding SE
XETRA:DMP
Long-Term Debt
€961.8m
CAGR 3-Years
19%
CAGR 5-Years
17%
CAGR 10-Years
N/A
ATAI Life Sciences NV
NASDAQ:ATAI
Long-Term Debt
$17.9m
CAGR 3-Years
108%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Long-Term Debt
€37.4B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
17%
Merck KGaA
XETRA:MRK
Long-Term Debt
€7.8B
CAGR 3-Years
-4%
CAGR 5-Years
4%
CAGR 10-Years
15%
MPH Health Care AG
XETRA:93M1
Long-Term Debt
€8.3m
CAGR 3-Years
41%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Long-Term Debt
€65.8m
CAGR 3-Years
669%
CAGR 5-Years
205%
CAGR 10-Years
N/A

See Also

What is Dermapharm Holding SE's Long-Term Debt?
Long-Term Debt
961.8m EUR

Based on the financial report for Jun 30, 2024, Dermapharm Holding SE's Long-Term Debt amounts to 961.8m EUR.

What is Dermapharm Holding SE's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
17%

Over the last year, the Long-Term Debt growth was -9%. The average annual Long-Term Debt growth rates for Dermapharm Holding SE have been 19% over the past three years , 17% over the past five years .

Back to Top